Phase
Condition
Inflammation
Cataracts
Eye Disorders/infections
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 years of age or older.
Diagnosis of cataract with intention to undergo routine, uncomplicated cataractsurgery.
Able to understand and sign an informed consent form.
Other protocol-defined inclusion criteria may apply.
Exclusion
Exclusion Criteria:
Glaucoma or ocular hypertension.
Use of topical or systemic non-steroidal anti-inflammatory drugs (NSAIDs) within 14days prior to surgery or planned use during the study. Low-dose acetylsalicylic acid (up to 100 mg/day) is allowed.
Use of anti-bacterial, anti-viral, or anti-fungal agents or ocular medications within 30 days prior to enrollment in the study or during study, as specified by protocol.
Secondary implantation or replacement of the intra-ocular lens (IOL) in the study eye.
Planned use of contact lenses in the study eye during the study period.
Cataract surgery in the contralateral eye within 30 days prior to the Screening Visit,or planned for the 3 weeks after the cataract surgery in the study eye.
History of clinically significant trauma to the study eye within the past 12 months.
Other protocol-defined exclusion criteria may apply.
Study Design
Connect with a study center
UNIFESP - Departamento de Oftalmologia
Sao Paulo, 04023-062
BrazilSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.